PMC:7029448 / 6277-7415 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"109","span":{"begin":14,"end":25},"obj":"Species"},{"id":"119","span":{"begin":137,"end":154},"obj":"Species"},{"id":"120","span":{"begin":368,"end":377},"obj":"Species"},{"id":"121","span":{"begin":379,"end":388},"obj":"Species"},{"id":"122","span":{"begin":390,"end":399},"obj":"Species"},{"id":"123","span":{"begin":401,"end":410},"obj":"Species"},{"id":"124","span":{"begin":412,"end":448},"obj":"Species"},{"id":"125","span":{"begin":453,"end":490},"obj":"Species"},{"id":"126","span":{"begin":1118,"end":1127},"obj":"Species"},{"id":"127","span":{"begin":156,"end":160},"obj":"Species"}],"attributes":[{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"Tax:694448"},{"id":"A119","pred":"tao:has_database_id","subj":"119","obj":"Tax:694448"},{"id":"A120","pred":"tao:has_database_id","subj":"120","obj":"Tax:290028"},{"id":"A121","pred":"tao:has_database_id","subj":"121","obj":"Tax:31631"},{"id":"A122","pred":"tao:has_database_id","subj":"122","obj":"Tax:277944"},{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"Tax:11137"},{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"Tax:1335626"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"Tax:694009"},{"id":"A126","pred":"tao:has_database_id","subj":"126","obj":"Tax:2697049"},{"id":"A127","pred":"tao:has_database_id","subj":"127","obj":"Tax:694448"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Expertise for coronavirus and other respiratory pathogens\nForty-five laboratories in 28 countries indicated having previous expertise in human coronavirus (HCoV) diagnostics. For two countries the two responding laboratories had no experience. Twenty-five laboratories in 19 countries indicated having experience in molecular diagnostics for all six additional HCoVs (HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E, Middle East respiratory syndrome CoV and severe acute respiratory syndrome CoV) [6]. Forty-four laboratories in 29 countries performed differential testing for other common respiratory pathogens of viral and bacterial origin. Overall, the 47 survey respondents indicated their ability to process a wide range of respiratory sample types, including nasopharyngeal swabs (n = 38), bronchoalveolar lavage (n = 36), oropharyngeal swab (n = 34), nasopharyngeal aspirate (n = 34), sputum (n = 34), (endo) tracheal aspirate (n = 32) and nasal wash (n = 29). In addition, a number of respondents indicated that their laboratories could process biopsy materials (n = 28) and whole blood, plasma, serum (n = 28) for 2019-nCoV detection."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":887,"end":893},"obj":"Body_part"},{"id":"T9","span":{"begin":1084,"end":1097},"obj":"Body_part"},{"id":"T10","span":{"begin":1099,"end":1104},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma312401"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Expertise for coronavirus and other respiratory pathogens\nForty-five laboratories in 28 countries indicated having previous expertise in human coronavirus (HCoV) diagnostics. For two countries the two responding laboratories had no experience. Twenty-five laboratories in 19 countries indicated having experience in molecular diagnostics for all six additional HCoVs (HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E, Middle East respiratory syndrome CoV and severe acute respiratory syndrome CoV) [6]. Forty-four laboratories in 29 countries performed differential testing for other common respiratory pathogens of viral and bacterial origin. Overall, the 47 survey respondents indicated their ability to process a wide range of respiratory sample types, including nasopharyngeal swabs (n = 38), bronchoalveolar lavage (n = 36), oropharyngeal swab (n = 34), nasopharyngeal aspirate (n = 34), sputum (n = 34), (endo) tracheal aspirate (n = 32) and nasal wash (n = 29). In addition, a number of respondents indicated that their laboratories could process biopsy materials (n = 28) and whole blood, plasma, serum (n = 28) for 2019-nCoV detection."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":887,"end":893},"obj":"Body_part"},{"id":"T2","span":{"begin":1084,"end":1097},"obj":"Body_part"},{"id":"T3","span":{"begin":1084,"end":1089},"obj":"Body_part"},{"id":"T4","span":{"begin":1099,"end":1104},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0007311"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Expertise for coronavirus and other respiratory pathogens\nForty-five laboratories in 28 countries indicated having previous expertise in human coronavirus (HCoV) diagnostics. For two countries the two responding laboratories had no experience. Twenty-five laboratories in 19 countries indicated having experience in molecular diagnostics for all six additional HCoVs (HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E, Middle East respiratory syndrome CoV and severe acute respiratory syndrome CoV) [6]. Forty-four laboratories in 29 countries performed differential testing for other common respiratory pathogens of viral and bacterial origin. Overall, the 47 survey respondents indicated their ability to process a wide range of respiratory sample types, including nasopharyngeal swabs (n = 38), bronchoalveolar lavage (n = 36), oropharyngeal swab (n = 34), nasopharyngeal aspirate (n = 34), sputum (n = 34), (endo) tracheal aspirate (n = 32) and nasal wash (n = 29). In addition, a number of respondents indicated that their laboratories could process biopsy materials (n = 28) and whole blood, plasma, serum (n = 28) for 2019-nCoV detection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T13","span":{"begin":453,"end":486},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Expertise for coronavirus and other respiratory pathogens\nForty-five laboratories in 28 countries indicated having previous expertise in human coronavirus (HCoV) diagnostics. For two countries the two responding laboratories had no experience. Twenty-five laboratories in 19 countries indicated having experience in molecular diagnostics for all six additional HCoVs (HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E, Middle East respiratory syndrome CoV and severe acute respiratory syndrome CoV) [6]. Forty-four laboratories in 29 countries performed differential testing for other common respiratory pathogens of viral and bacterial origin. Overall, the 47 survey respondents indicated their ability to process a wide range of respiratory sample types, including nasopharyngeal swabs (n = 38), bronchoalveolar lavage (n = 36), oropharyngeal swab (n = 34), nasopharyngeal aspirate (n = 34), sputum (n = 34), (endo) tracheal aspirate (n = 32) and nasal wash (n = 29). In addition, a number of respondents indicated that their laboratories could process biopsy materials (n = 28) and whole blood, plasma, serum (n = 28) for 2019-nCoV detection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T48","span":{"begin":137,"end":142},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T49","span":{"begin":560,"end":567},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T50","span":{"begin":708,"end":709},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T51","span":{"begin":819,"end":821},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T52","span":{"begin":848,"end":850},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T53","span":{"begin":882,"end":884},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T54","span":{"begin":899,"end":901},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T55","span":{"begin":976,"end":977},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T56","span":{"begin":1078,"end":1089},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T57","span":{"begin":1078,"end":1089},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T58","span":{"begin":1091,"end":1097},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"Expertise for coronavirus and other respiratory pathogens\nForty-five laboratories in 28 countries indicated having previous expertise in human coronavirus (HCoV) diagnostics. For two countries the two responding laboratories had no experience. Twenty-five laboratories in 19 countries indicated having experience in molecular diagnostics for all six additional HCoVs (HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E, Middle East respiratory syndrome CoV and severe acute respiratory syndrome CoV) [6]. Forty-four laboratories in 29 countries performed differential testing for other common respiratory pathogens of viral and bacterial origin. Overall, the 47 survey respondents indicated their ability to process a wide range of respiratory sample types, including nasopharyngeal swabs (n = 38), bronchoalveolar lavage (n = 36), oropharyngeal swab (n = 34), nasopharyngeal aspirate (n = 34), sputum (n = 34), (endo) tracheal aspirate (n = 32) and nasal wash (n = 29). In addition, a number of respondents indicated that their laboratories could process biopsy materials (n = 28) and whole blood, plasma, serum (n = 28) for 2019-nCoV detection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T49","span":{"begin":0,"end":57},"obj":"Sentence"},{"id":"T50","span":{"begin":58,"end":174},"obj":"Sentence"},{"id":"T51","span":{"begin":175,"end":243},"obj":"Sentence"},{"id":"T52","span":{"begin":244,"end":496},"obj":"Sentence"},{"id":"T53","span":{"begin":497,"end":637},"obj":"Sentence"},{"id":"T54","span":{"begin":638,"end":962},"obj":"Sentence"},{"id":"T55","span":{"begin":963,"end":1138},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Expertise for coronavirus and other respiratory pathogens\nForty-five laboratories in 28 countries indicated having previous expertise in human coronavirus (HCoV) diagnostics. For two countries the two responding laboratories had no experience. Twenty-five laboratories in 19 countries indicated having experience in molecular diagnostics for all six additional HCoVs (HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E, Middle East respiratory syndrome CoV and severe acute respiratory syndrome CoV) [6]. Forty-four laboratories in 29 countries performed differential testing for other common respiratory pathogens of viral and bacterial origin. Overall, the 47 survey respondents indicated their ability to process a wide range of respiratory sample types, including nasopharyngeal swabs (n = 38), bronchoalveolar lavage (n = 36), oropharyngeal swab (n = 34), nasopharyngeal aspirate (n = 34), sputum (n = 34), (endo) tracheal aspirate (n = 32) and nasal wash (n = 29). In addition, a number of respondents indicated that their laboratories could process biopsy materials (n = 28) and whole blood, plasma, serum (n = 28) for 2019-nCoV detection."}